Advertisement

Lipid modification induced by lipoprotein apheresis could mirrored mid-regional-pro-adrenomedullin plasma levels?

      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Del Ry.S.
        • Cabiati M.
        • Bianchi V.
        • Caponi L.
        • Di Cecco P.
        • Marchi B.
        • et al.
        Mid-regional-pro-adrenomedullin plasma levels are increased in obese adolescents.
        Eur J Nutr. 2016; 55: 1255-1260
        • Lainchbury J.G.
        • Troughton R.W.
        • Lewis L.K.
        • Yandle T.G.
        • Richards A.M.
        • Nicholls M.G.
        Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers.
        J Clin Endocrinol Metab. 2000; 85: 1016-1020
        • Khan S.Q.
        • O'Brien R.J.
        • Struck J.
        • Quinn P.
        • Morgenthaler N.
        • Squire I.
        • et al.
        Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
        J Am Coll Cardiol. 2007; 49: 1525-1532
        • Viaggi B.
        • Poole D.
        • Tujjar O.
        • Marchiani S.
        • Ognibene A.
        • Finazzi S.
        Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
        PLoS One. 2018; 13e0201491
        • Padró T.
        • Vilahur G.
        • Badimon L.
        Dyslipidemias and microcirculation.
        Curr Pharm Des. 2018; 24: 2921-2926
        • Sampietro T.
        • Tuoni M.
        • Ferdeghini M.
        • Ciardi A.
        • Marraccini P.
        • Prontera C.
        • et al.
        Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia.
        Circulation. 1997; 96: 1381-1385
        • Albertini R.
        • Cerutti L.
        • Sessa N.
        • Palladini G.
        Adrenomedullin and related peptides: from physiology to diagnostics.
        Biochim Clin. 2013; 37: 86-90
        • Gottsäter M.
        • Ford L.B.
        • Ostling G.
        • Persson M.
        • Nilsson P.M.
        • Melander O.
        Adrenomedullin is a marker of carotid plaques and intima-media thickness as well as brachial pulse pressure.
        J Hypertens. 2013; 31: 1959-1965
        • Morgenthaler N.G.
        • Struck J.
        • Alonso C.
        • Bergmann A.
        Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
        Clin Chem. 2005; 51: 1823-1829
        • Puntoni M.
        • Sbrana F.
        • Bigazzi F.
        • Minichilli F.
        • Ferdeghini E.
        • Sampietro T.
        Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemia.
        Lipids Health Dis. 2011; 10: 185
        • Sampietro T.
        • Sbrana F.
        • Dal Pino B.
        • Bigazzi F.
        • Ripoli A.
        • Marzullo P.
        • Gimelli A.
        • et al.
        Coronary microcirculatory blood flow significantly increases upon acute and chronic cholesterol lowering: evaluation by cadmium-zinc-telluride cardiac imaging stress test.
        Eur J Prev Cardiol. 2022; 29: e272-e274
        • Adorni M.P.
        • Zimetti F.
        • Puntoni M.
        • Bigazzi F.
        • Sbrana F.
        • Minichilli F.
        • et al.
        Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.
        J Lipid Res. 2012; 53: 984-989
        • Otto C.
        • Geiss H.C.
        • Empen K.
        • Parhofer K.G.
        Long-term reduction of C-reactive protein concentration by regular LDL apheresis.
        Atherosclerosis. 2004; 174: 151-156